2-121530932-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 1P and 2B. PP5BP4BS2_Supporting
The NM_001395891.1(CLASP1):​c.196-607G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000121 in 700,266 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: đť‘“ 0.00014 ( 0 hom., cov: 32)
Exomes đť‘“: 0.00011 ( 0 hom. )
Consequence
CLASP1
NM_001395891.1 intron
NM_001395891.1 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.82
Genes affected
CLASP1 (HGNC:17088): (cytoplasmic linker associated protein 1) CLASPs, such as CLASP1, are nonmotor microtubule-associated proteins that interact with CLIPs (e.g., CLIP170; MIM 179838). CLASP1 is involved in the regulation of microtubule dynamics at the kinetochore and throughout the spindle (Maiato et al., 2003 [PubMed 12837247]).[supplied by OMIM, Mar 2008]
RNU4ATAC (HGNC:34016): (RNA, U4atac small nuclear) The small nuclear RNA (snRNA) encoded by this gene is part of the U12-dependent minor spliceosome complex. In addition to the encoded RNA, this ribonucleoprotein complex consists of U11, U12, U5, and U6atac snRNAs. The U12-dependent spliceosome acts on approximately 700 specific introns in the human genome. Defects in this gene are a cause of microcephalic osteodysplastic primordial dwarfism type 1 (MOPD). [provided by RefSeq, Jul 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -1 ACMG points.
PP5
Variant 2-121530932-C-T is Pathogenic according to our data. Variant chr2-121530932-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 692041.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=2, Uncertain_significance=1, Pathogenic=1}. Variant chr2-121530932-C-T is described in Lovd as [Pathogenic].
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.28). . Strength limited to SUPPORTING due to the PP5.
BS2
High AC in GnomAd4 at 22 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLASP1 | NM_001395891.1 | c.196-607G>A | intron_variant | ENST00000696935.1 | NP_001382820.1 | |||
RNU4ATAC | NR_023343.1 | n.53C>T | non_coding_transcript_exon_variant | 1/1 | ||||
CLASP1-AS1 | XR_001739683.2 | n.608+157C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLASP1 | ENST00000696935.1 | c.196-607G>A | intron_variant | NM_001395891.1 | ENSP00000512981 | A2 | ||||
RNU4ATAC | ENST00000580972.1 | n.52C>T | non_coding_transcript_exon_variant | 1/1 | ||||||
CLASP1-AS1 | ENST00000577914.1 | n.354+157C>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152192Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
22
AN:
152192
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000161 AC: 21AN: 130510Hom.: 0 AF XY: 0.000183 AC XY: 13AN XY: 71230
GnomAD3 exomes
AF:
AC:
21
AN:
130510
Hom.:
AF XY:
AC XY:
13
AN XY:
71230
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000115 AC: 63AN: 548074Hom.: 0 Cov.: 0 AF XY: 0.000125 AC XY: 37AN XY: 296768
GnomAD4 exome
AF:
AC:
63
AN:
548074
Hom.:
Cov.:
0
AF XY:
AC XY:
37
AN XY:
296768
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000145 AC: 22AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74368
GnomAD4 genome
AF:
AC:
22
AN:
152192
Hom.:
Cov.:
32
AF XY:
AC XY:
16
AN XY:
74368
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:5Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Pathogenic:2Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 19, 2022 | This variant occurs in the RNU4ATAC gene, which encodes an RNA molecule that does not result in a protein product. This variant is present in population databases (rs180755563, gnomAD 0.04%). This variant has been observed in individual(s) with Lowry-Wood syndrome (PMID: 30368667). ClinVar contains an entry for this variant (Variation ID: 692041). This variant is located within the 5' stem-loop region of the RNU4ATAC RNA, which includes the 15.5K binding site and is important for spliceosome assembly (PMID: 32628740). A significant number of disease-associated RNU4ATAC variants are found in this region (PMID: 32628740, 30368667). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2022 | RNU4ATAC: PM3:Strong, PM1, PM5, PM2:Supporting - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 12, 2024 | Located in the critical region of the 5' stem-loop (PMID: 26522830); Changes the Watson-Crick match to a wobble base pair at a position where a Watson-Crick match is not conserved, which is not expected to affect the secondary structure/function; Located in a stem of the RNU4ATAC non-coding RNA; This variant is associated with the following publications: (PMID: 30368667, 21474760, 32628740, Alomrani 2022[Review]) - |
Lowry-Wood syndrome Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 11, 2020 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego | Jul 16, 2018 | This variant occurs in an element of major importance for splicing in the 5' Stem-loop critical region of the snRNA molecule and is therefore predicted to disrupt minor intron splicing activity (PMID: 26522830). A different nucleotide change as this position was previously reported in a compound heterozygous change in a patient with microcephalic osteodysplastic primordial dwarfism type 1 (MOPD 1) (PMID: 21474761). The variant is absent from the ExAC and gnomAD population databases and thus is presumed to be rare. This variant was detected in trans with another CLASP1 variant classified as likely pathogenic . Based on the available evidence the variant is classified as Likely Pathogenic. - |
Osteodysplastic primordial dwarfism, type 1 Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | Service de Génétique Moléculaire, Hôpital Robert Debré | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at